Combining phentermine and tirzepatide may amplify certain adverse effects and introduce unique safety concerns that require careful clinical monitoring
Announces Exclusive Strategic Marketing Partnership with Mixed Martial Arts Group Limited May 12, 2026 The Precision Peptide Company Nears Commercial Launch of Needle-Free BPC-157 Patch as Final Testing Advances May 7, 2026 C$1.3 Million in Proceeds Received by The Precision Peptide Company from Warrant Exercises May 5, 2026 The Precision Peptide Company Grants RSUs and Stock Options and Settles Debt May 4, 2026 Must Read OTC Markets/SEC policy on stock promotion and investor protection COMPENSATION DISCLOSURE EMC has been paid $575,000 by Pangea Wellness Inc
Injectable polypeptide hydrogel-based co-delivery of vaccine and immune checkpoint inhibitors improves tumor immunotherapy
IC/PBS usually occurs with not only pain, but significant urgency to urinate with many patients having frequency to void over 20 times per day, although little urine will be released
In some embodiments, the otoprotectant is a compound of Formula (XI): wherein: R 1 is C 6 -C 10 aryl or C 3 -C 9 heteroaryl, wherein C 6 -C 10 aryl and C 3 -C 9 heteroaryl are optionally substituted with one or more R 4